142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

Chasing the monkey: Fighting prescription opioid abuse in the Midwest

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Wednesday, November 19, 2014 : 11:10 AM - 11:30 AM

Joan Duwve, MD, MPH , Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN
One of the most pressing public health issues the United States is currently facing is the prescription drug abuse epidemic. The Centers for Disease Control and Prevention report that 16,651 people died of prescription painkiller overdoses in2010 2009; nonmedical use of prescription painkillers costs the US healthcare system more than $72.5 billion each year. The problem of prescription drug misuse  and abuse is complex, requiring a multi-disciplinary approach. Public health, medicine, and law enforcement agencies have come together in several states to establish policies and programs to prevent overprescribing and mitigate the dangerous effects of prescription drug misuse and abuse at the state level. Indiana launched the Prescription Drug Abuse Task Force that developed the provider toolkit, Do No Harm, to educated prescribers of the new prescribing rules set forth by the Indiana Medical Licensing Board and set a standard for safe, effective pain management.This presentation will share the process of developing the Toolkit and its implementation in practices across the state.

Learning Areas:

Program planning
Public health administration or related administration
Public health or related public policy

Learning Objectives:
Name challenges associated with combatting the prescription drug abuse problem Identify strategies for successful prevention programs

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have a strong interest in injury prevention and infectious diseases/immunizations. I co-chair the State Suicide Prevention Advisory Committee and the State Prescription Drug Abuse Prevention Task Force. I have worked diligently to expand access to immunization services at local health departments and pharmacies.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.